Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Advanced Gastric Cancer × 130-nm albumin-bound paclitaxel × Clear all

Phase

Phase 4 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thymoma 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Large Cell 1 Carcinoma 1 Advanced Gastric Cancer 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

lobaplatin 1 S 1 (combination) 1 Ramucirumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06169410 2024-01-23

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Xijing Hospital

Phase 4 Unknown

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡